최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.21 no.1, 2003년, pp.54 - 65
이규찬 (가천의과대학교 방사선종양학과) , 김명곤 (고려대학교 의과대학 생화학교실) , 김주영 (가천의과대학교 방사선종양학과) , 황유진 (가천의과대학교 분자생물학연구실) , 최명선 (고려대학교 방사선종양학교실) , 김철용 (고려대학교 방사선종양학교실)
Purpose : To analyze the gene expression Profiles of uterine ceulcal cancer, and its variation after radiation therapy, with or without concurrent chemotherapy, using a CDNA microarray. Materials and Methods :Sixteen patients, 8 with squamous ceil carcinomas of the uterine cervix, who were treated w...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841
Central Cancer Registry Center in Korea. Ministry of Health and Welfare, Republic of Korea. Annual report of the central cancer registry in Korea (1999. 1. -1999. 12.) April, 2001
Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137-1143
Kang OC, Choi EK, Chung WK, et al. Concurrent chemoraiotherapy in locally advanced carcinoma of the uterine cervix. J Korean Soc Ther Radiol 1998;16:311-323
SChena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470
Wang K, Gan L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999;229:101-108
Bertucci F, Houlgatte R, Benziane A, et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 2000;9:2981-2991
Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511
Park GH, Choe J, Choo HJ, Park YG, Sohn J, Kim MK. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray. Exp Mol Med 2002;34(3):184-193
Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95(25):14863-14868
Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000;110:374-381
Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001;33:832-840
Bertucci F, Bernard K, Loriod B, et al. Sensitivity issues in DNA array-based expression measurements and perfor- mance of nylon microarrays for small samples. Hum Mol Genet 1999;8:1715-1722
Yoo HS. 21C Frontier Cancer Genome Project of Korea. J Korean Cancer Asso 2001;33(S):4
Achary MP, Jaggernauth W, Gross E, Alfieri A, Klinger HP, Vikram B. Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different eDNA microarray patterns of gene expression. Cytogenet Cell Genet 2000;91:39-43
Kitahara O, Katagiri T, Tsunoda T, Harima V, Nakamura V. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by eDNA microarray analysis. Neoplasia 2002:4(4):295-303
Voganathan TN, Costello P, Chen X, et al. Integrin-linked kinase (ILK): a 'hot' therapeutic target. Biochem Pharmacol 2000;60(8):1115-1119
White DE, Cardiff RD, Dedhar S, Muller WJ. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 2001;20(48):7064-7072
SCandurro AB, Weldon CW, Figueroa VG, Alam J, Beckman BS. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol 2001;19(1):129-135
D'Amico M, Hulit J, Amanatullah DF, et al. The integrinlinked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Bioi Chem 2000;275(42): 32649-32657
Dedhar S, Williams B, Hannigan G. Integrin-linked kinase (ILK) : a regulator of integrin and growth-factor signaling. Trends Cell Bioi 1999;9(8):319-323
Voganathan N, Vee A, Zhang Z, et al. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties. Pharmacol Ther 2002;93(2-3):233
Persad S, Attwell S, Gray V, et al. Inhibition of integrinlinked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTENmutant prostate cancer cells. Proc Natl Acad Sci USA 2000; 97(7):3207-3212
Graff JR, Deddens JA, Konicek BW, et al. Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 2001;7(7):1987-1991
Marotta A, Tan C, Gray V, et al. Dysregulation of integrin- linked kinase (ILK) signaling in colonic polyposis. Oncogene 2001;20(43):6250-6257
Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signaling as a target for cancer intervention strategies. Endocr Relat Cancer 2001;8(3):161-173
Ostman A, Bohmer FD. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Bioi 2001;11(6):258-266
Majercakova P. Role of protein phosphorylation in the development of tumors. Sb Lek 2000;101(3):215-228
Chernoff J. Protein tyrosine phosphatases as negative regulators of mitogenic signaling. J Cell Physiol 1999;180(2):173-181
Fischer EH. Cell signaling by protein tyrosine phosphorylation. Adv Enzyme Regul 1999;39:359-369
Bixby JL. Ligands and signaling through receptor-type tyrosine phosphatases. UBMB Life 2001;51(3):157-163
Smits VA, Medema RH. Checking out the G(2)/M transition. Biochem Biophys Acta 2001;1519(1-2):1-12
Arellano M, Moreno S. Regulation of CDK!cyciin complexes during the cell cycle. Int J Biochem Cell Bioi 1997;29(4):559573
Gross I, Bassit B, Benezra M, Licht JD. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing\ ras activation. J Bioi Chem 2001 ;276(49):46460-46468
Egan JE, Hall AB, Vatsula BA, Bar-Sagi D. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc Natl Acad Sci USA 2002;99(9):6041-6046
Wong ES, Fong CW, Lim J, et al. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signaling. EMBO J 2002;21(18):4796-4808
Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284(5422):1994-1998
Vajkoczy P, Farhadi M, Gaumann A, et al. Microtumor growth initiates angiogenic sprouting with simUltaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002;109(6):777-785
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.